EDGAR Filing Documents for 0001047469-19-006397

Form PRE 14A - Other preliminary proxy statements:

SEC Accession No. 0001047469-19-006397

Filing Date

2019-11-19

Accepted

2019-11-19 16:06:38

Documents

Period of Report

2019-12-27

Document Format Files

Seq	Description	Document	Type	Size
1	PRE 14A	a2240110zpre14a.htm	PRE 14A	536596
2	G231002BGI001.JPG	g231002bgi001.jpg	GRAPHIC	1461
3	G875589.JPG	g875589.jpg	GRAPHIC	9294
4	G330463.JPG	g330463.jpg	GRAPHIC	17226
5	G84753.JPG	g84753.jpg	GRAPHIC	65276
	Complete submission text file	0001047469-19-006397.txt		666680

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108

Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123

BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37686 | Film No.: 191231186
SIC: 2834 Pharmaceutical Preparations